Answers are grounded in this paper and cite their sources.
Plants produce chemically diverse compounds for defence and survival, many of which exhibit biological activity and offer promising starting points for drug discovery. This study thus investigated natural compounds as potential inhibitors of tyrosinase, a key enzyme in melanin production and an established target in the treatment of hyperpigmentation. A quantitative structure–activity relationship (QSAR) machine-learning model was developed using ChEMBL tyrosinase bioactivity data and property-matched decoys. Ten models, including decision trees, random forests and gradient boosting, were evaluated; logistic regression was selected for virtual screening. To make the model generalise to unseen chemistry, the model was tested on compounds that were required to have Tanimoto similarity of 0.40 or less to every training compound and to share no Bemis–Murcko scaffold with them. The model achieved an AUC of 0.82 (95% confidence interval [CI], 0.78–0.86), compared with 0.56 using physicochemical properties alone. The frozen model was then used to screen 404,570 natural products from COCONUT (COlleCtion of Open Natural prodUcTs) and IMPPAT (Indian Medicinal Plants, Phytochemistry And Therapeutics). Of the top 1% of predictions, 1,694 compounds were both structurally novel and represented new scaffolds. Following computational filters for predicted skin permeability and potentially reactive chemical groups indicating skin irritation, the 100 highest-scoring candidates were selected for molecular docking. Docking reproduced the crystallographic tropolone binding pose with a root-mean-square deviation (RMSD) of 1.20 Å, while the most predictive docking score achieved an AUC of 0.64 (95% CI, 0.61–0.66). Among the ten highest-ranked candidates, two were associated with Anisomeles indica (Indian catmint) and two with Phaseolus lunatus (lima beans). These candidates warrant experimental validation and further investigation for potential dermatological applications.
No takes yet. Share an insight, caveat, or question.
Anand Sharma (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: